Skip to content

UPB

Upstream Bio, Inc.

NASDAQ · USHealthcareBiotechnology
$6.98-0.43%

Price as of Jul 20, 2026

UPB capital

Upstream Bio, Inc. capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity
0.00x
Net debt / equity
-0.31x
Debt / assets
0.00x
Debt / EBITDA
-0.01x
Net debt / EBITDA
0.61x

Liquidity & coverage

Current ratio
23.14x
Quick ratio
23.14x
Cash ratio
21.55x
Interest coverage
EBITDA / interest
Working capital
$302.6M

Cash & dividend

FCF / debt
-125.68x
Cash flow / debt
-125.64x
Dividend per share
Dividend yield
Dividend growth 1y

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.